Walgreens Boots Alliance (NASDAQ:WBA) Reaches New 1-Year Low at $18.32

Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $18.32 and last traded at $18.38, with a volume of 3164714 shares. The stock had previously closed at $19.18.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a "buy" rating on the stock in a report on Wednesday, April 3rd. Bank of America decreased their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an "underperform" rating for the company in a research note on Tuesday, March 26th. Raymond James reissued a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Barclays assumed coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an "underweight" rating and a $21.00 price target for the company. Finally, TheStreet raised shares of Walgreens Boots Alliance from a "d+" rating to a "c-" rating in a research note on Monday, January 8th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $24.36.

Read Our Latest Analysis on Walgreens Boots Alliance


Walgreens Boots Alliance Trading Down 6.0 %

The business's 50 day simple moving average is $21.19 and its 200 day simple moving average is $22.14. The stock has a market cap of $15.55 billion, a price-to-earnings ratio of -2.57, a PEG ratio of 1.19 and a beta of 0.73. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company's quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.16 EPS. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan bought 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of the business's stock in a transaction on Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now directly owns 4,456 shares in the company, valued at $99,992.64. The disclosure for this purchase can be found here. Insiders own 17.40% of the company's stock.

Institutional Investors Weigh In On Walgreens Boots Alliance

Several institutional investors and hedge funds have recently bought and sold shares of WBA. Candriam Luxembourg S.C.A. grew its stake in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator's stock worth $2,842,000 after acquiring an additional 310 shares in the last quarter. Signet Financial Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1.0% during the 1st quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator's stock valued at $1,588,000 after buying an additional 334 shares in the last quarter. Cooper Financial Group raised its holdings in shares of Walgreens Boots Alliance by 4.2% during the 3rd quarter. Cooper Financial Group now owns 10,982 shares of the pharmacy operator's stock valued at $244,000 after buying an additional 442 shares in the last quarter. New York Life Investment Management LLC boosted its stake in Walgreens Boots Alliance by 0.4% in the third quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator's stock worth $2,547,000 after buying an additional 499 shares in the last quarter. Finally, Laurel Wealth Advisors Inc. grew its position in Walgreens Boots Alliance by 5.1% during the first quarter. Laurel Wealth Advisors Inc. now owns 10,563 shares of the pharmacy operator's stock valued at $473,000 after acquiring an additional 509 shares during the last quarter. Institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Featured Articles and Offers

Search Headlines: